{
  "author": {
    "name": "Chris Dunlavy",
    "webUrl": "/author/profile/chris-dunlavy/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 1,
    "social": [],
    "articles": [
      {
        "uri": "/2019/10/02/the-epidemic-no-one-is-talking-about/",
        "title": "The epidemic no one is talking about",
        "byline": "Chris Dunlavy",
        "kicker": "Commentary",
        "prettyDate": "October 02, 2019",
        "timeToRead": "5 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2019/09/XanaxPillsShutterstock.jpg",
          "width": "620",
          "height": "372"
        },
        "authors": [
          {
            "webUrl": "/author/profile/chris-dunlavy/",
            "name": "Chris Dunlavy"
          }
        ],
        "kickerNode": [
          {
            "uri": "/commentary/",
            "sectionName": "Commentary"
          }
        ],
        "summary": "It's time we addressed the nation's benzodiazepine problem.",
        "body": null
      }
    ]
  }
}